+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Intravascular Temperature Management Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163046
The global intravascular temperature management market size was valued at USD 314.15 Million in 2024, driven by the increasing prevalence of chronic diseases and ageing population across the globe. The market is anticipated to grow at a CAGR of 3.10% during the forecast period of 2025-2034 to achieve a value of USD 426.31 Million by 2034.

Intravascular Temperature Management: Introduction

Intravascular temperature management is a technique that is used for the management of the body's core temperature while undergoing particular medical procedures or conditions. It is also known as cooling or warming technique in medical terms. The body temperature is managed by inserting the specialized catheters or devices into the blood vessels which helps in regulating the body's temperature by maintaining temperature of the blood stream. The main focus of intravascular temperature management technique is to maintain the patient's body temperature within a certain restricted range in order to improve recovery and patient's outcome.

Global Intravascular Temperature Management Market Analysis

Intravascular temperature management has multiple applications, depending upon the requirement of the condition. It can be used in multiple clinical settings, such as during the cardiac surgeries, post cardiac care, neurosurgeries, or sepsis, among others. It is also widely used in hypothermia, a condition where prominent organs of the body as brain and other organs are being protected from the effect of a cardiac arrest or traumatic brain injury by using the controlled cooling technique.

The several key trends running in the intravascular temperature management market expansion include the development of more advanced devices, such as catheters, with even better temperature control capabilities and easy to use devices. There is an escalating focus on the use of minimally invasive procedures and techniques in intravascular temperature management.

Minimally invasive procedures are known and preferred for their comparatively minimal incisions and to enable them even smaller equipment are required to be developed, hence the development of even smaller catheters and other devices with more flexibility and functionality is ongoing in the market. Some other key trends in the market include personalized temperature management, and involvement of new technologies along with research and studies owing to the intravascular temperature management market growth.

Global Intravascular Temperature Management Market Segmentations

Intravascular Temperature Management Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

  • Intravascular Cooling
  • Intravascular Warming

Market Breakup by Medical Condition

  • Cardiac Arrest
  • Traumatic Brain Injury (TBI)
  • Stroke
  • Myocardial Infection
  • Others

Market Breakup by Application

  • Pre-Operative Care
  • Operative Care
  • Post-Operative Care
  • Perioperative Care
  • Acute/Critical Care

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Intravascular Temperature Management Market Overview

The market for intravascular temperature management has seen evident growth in the past and is expected to be growing rapidly in coming years as well. The growth of the market is driven by various factors, including the involvement of minimally invasive procedures. The increasing prevalence of the chronic diseases and increasing geriatric population has increased the demand for intravascular temperature management solutions in healthcare industry, propelling the intravascular temperature management market development.

Additionally, rapidly advancing technologies and utilization of new advanced devices in the procedure of temperature management has also increased the demand for intravascular temperature management in the market.

Intravascular Temperature Management Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Lonza Group
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
  • Qiagen NV
  • Promega Corporation
  • SignaGen Laboratories
  • Merck KGaA
  • Altogen Biosystems
  • Polyplus-transfection SA
  • Mirus Bio

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Intravascular Temperature Management Market Overview
3.1 Global Intravascular Temperature Management Market Historical Value (2018-2024)
3.2 Global Intravascular Temperature Management Market Forecast Value (2025-2034)
4 Global Intravascular Temperature Management Market Landscape
4.1 Intravascular Temperature Management: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Intravascular Temperature Management: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Intravascular Temperature Management Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Intravascular Temperature Management Market Segmentation
6.1 Global Intravascular Temperature Management Market by Type
6.1.1 Market Overview
6.1.2 Intravascular Cooling
6.1.3 Intravascular Warming
6.2 Global Intravascular Temperature Management Market by Medical Condition
6.2.1 Market Overview
6.2.2 Cardiac Arrest
6.2.3 Traumatic Brain Injury (TBI)
6.2.4 Stroke
6.2.5 Myocardial Infection
6.2.6 Others
6.3 Global Intravascular Temperature Management Market by Application
6.3.1 Market Overview
6.3.2 Pre-Operative Care
6.3.3 Operative Care
6.3.4 Post-Operative Care
6.3.5 Perioperative Care
6.3.6 Acute/Critical Care
6.4 Global Intravascular Temperature Management Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Intravascular Temperature Management Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Intravascular Temperature Management Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Intravascular Temperature Management Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Intravascular Temperature Management Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Intravascular Temperature Management Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Lonza Group
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Bio-Rad Laboratories, Inc.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Thermo Fisher Scientific
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Qiagen NV
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Promega Corporation
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 SignaGen Laboratories
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Merck KGaA
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Altogen Biosystems
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Polyplus-transfection SA
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Mirus Bio
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Lonza Group
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
  • Qiagen NV
  • Promega Corporation
  • SignaGen Laboratories
  • Merck KGaA
  • Altogen Biosystems
  • Polyplus-transfection SA
  • Mirus Bio